Nufarm Gets New Bull as Prospects Improve -- Market Talk

Dow Jones
May 28

Nufarm gets a new bull in Jefferies as the crop-chemicals supplier reaches an inflection point. "We upgrade Nufarm to buy following confirmation of cyclical inflection in Crop Protection and Seeds, alongside improved cashflow outlook that provides viable pathway to deleveraging," analyst Ramoun Lazar says. Jefferies highlights improved prospects for Nufarm's Growth Platforms business. It says omega-3 costs are easing, while the business's capital profile is reducing. That should give management more options over the longer term, especially as regulation is pared back in Europe and China. "We believe risks around leverage have abated," Jefferies adds. Its price target rises 32% to A$3.50/share. Nufarm ended Wednesday at A$2.91. (david.winning@wsj.com; @dwinningWSJ)

 
 

(END) Dow Jones Newswires

May 27, 2026 18:54 ET (22:54 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10